Edwards lifesciences announces $500 million accelerated share repurchase

Irvine, calif.--(business wire)--edwards lifesciences (nyse: ew) today announced that it has executed an accelerated share repurchase agreement ("asr") to repurchase $500 million of edwards' common stock. with this transaction, edwards has repurchased more than $800 million of shares in 2025. under the terms of this asr, edwards will receive an initial delivery of approximately 5 million shares and the remainder at the maturity of the asr. the final number of shares to be repurchased will be ba.
EW Ratings Summary
EW Quant Ranking